Financе
Nasdaq to Delist BNB Treasury Firm Windtree Therapeutics, Stock Crashes 76%

Windtree Therapeutics will be delisted from the Nasdaq Capital Market after failing to meet listing requirements, a decision that triggered a massive sell-off in its stock.
Click to rate this post!
[Total: 0 Average: 0]


